Lymphoma

Showing NaN - NaN of 111

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia

Completed
  • Leukemia
  • +4 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 19, 2023

    Bone Marrow Cancer, Leukemia, Lymphoma Trial in Philadelphia (Virtual reality, Environmental changes)

    Enrolling by invitation
    • Bone Marrow Cancer
    • +4 more
    • Virtual reality
    • Environmental changes
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Jan 9, 2023

    Ovarian Reserve in Younger Newly Diagnosed Lymphomas

    Active, not recruiting
    • Anaplastic Large Cell Lymphoma
    • +4 more
    • Laboratory Biomarker Analysis
    • Questionnaire Administration
    • Birmingham, Alabama
    • +106 more
    Jan 11, 2023

    Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

    Recruiting
    • Clinical Stage I Cutaneous Melanoma AJCC v8
    • +33 more
    • Informational Intervention
    • +4 more
    • Los Angeles, California
    • +4 more
    Dec 14, 2022

    Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

    Recruiting
    • Neoplasms
    • +2 more
    • La Jolla, California
    • +15 more
    Dec 7, 2022

    Lymphoma Trial in United States (itacitinib, ibrutinib)

    Completed
    • Lymphoma
    • Scottsdale, Arizona
    • +20 more
    Nov 14, 2022

    Lymphoma Trial in Worldwide (Parsaclisib)

    Active, not recruiting
    • Lymphoma
    • Phoenix, Arizona
    • +82 more
    Oct 14, 2022

    Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +49 more
    • Birmingham, Alabama
    • +1429 more
    Aug 17, 2022

    Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

    Completed
    • Lymphoma
    • Nonneoplastic Condition
    • bleomycin sulfate
    • +11 more
    • Tucson, Arizona
    • +422 more
    Aug 16, 2022

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +7 more
    • Duarte, California
    • +26 more
    Aug 11, 2022

    Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • +3 more
    • Oral repotrectinib (TPX-0005)
    • Los Angeles, California
    • +27 more
    Aug 9, 2022

    Cardiotoxicity, Toxicity Due to Chemo, Breast Cancer Trial in Duarte, Philadelphia, West Chester (Biomarker Guided Intervention)

    Recruiting
    • Cardiotoxicity
    • +5 more
    • Biomarker Guided Intervention
    • Duarte, California
    • +2 more
    Jul 29, 2022

    Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

    Active, not recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +3 more
    • Birmingham, Alabama
    • +42 more
    Jul 20, 2022

    Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

    Active, not recruiting
    • Breast Cancer
    • +10 more
    • Los Angeles, California
    • +7 more
    Jun 21, 2022

    Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

    Recruiting
    • Leukemia
    • +3 more
    • San Francisco, California
    • +3 more
    Jun 14, 2022

    Lymphoma Trial in Philadelphia (Glucarpidase)

    Recruiting
    • Lymphoma
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Apr 21, 2022

    Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

    Active, not recruiting
    • Lymphoma
    • rituximab
    • +3 more
    • Greenbrae, California
    • +226 more
    Mar 7, 2022

    FDG-PET/CT Imaging as Early Predictor of DP

    Completed
    • Lymphoma
    • There is no intervention
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Mar 7, 2022

    Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)

    Completed
    • Lymphoma
    • Acute Lymphoblastic Leukemia
    • Apixaban
    • No systemic anticoagulant prophylaxis
    • Phoenix, Arizona
    • +95 more
    Feb 10, 2022

    Lymphoma, Advanced Solid Tumor Trial in Philadelphia (Gamitrinib)

    Recruiting
    • Lymphoma
    • Advanced Solid Tumor
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Feb 2, 2022

    Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)

    Active, not recruiting
    • Lymphoma
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Gilbert, Arizona
    • +53 more
    Jan 25, 2022

    Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)

    Completed
    • Breast Cancer
    • Lymphoma
    • Los Angeles, California
    • +50 more
    Dec 6, 2021

    Lymphoma Trial in Worldwide (Nivolumab)

    Completed
    • Lymphoma
    • Birmingham, Alabama
    • +49 more
    Nov 24, 2021

    Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

    Recruiting
    • Leukemia
    • +2 more
    • Alpha Beta T cell depletion
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Oct 27, 2021

    Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

    Active, not recruiting
    • Acute Leukemia
    • +3 more
    • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
    • +5 more
    • Birmingham, Alabama
    • +38 more
    Oct 25, 2021